AB Corporate Bond ETF (NASDAQ:EYEG) Stock Short Interest Drops 95.5%

AB Corporate Bond ETF (NASDAQ:EYEG) was the recipient of a large drop in short interest in October. As of October 30th, there was short interest totaling 43 shares, a drop of 95.5% from the October 15th total of 950 shares. Based on an average daily volume of 5,020 shares, the days-to-cover ratio is currently 0.0 days. Currently, 0.0% of the company’s stock are sold short.

AB Corporate Bond ETF Stock Performance

Shares of NASDAQ EYEG traded down $0.07 during trading on Wednesday, reaching $33.70. The stock had a trading volume of 35 shares, compared to its average volume of 542. The company has a debt-to-equity ratio of 0.01, a quick ratio of 3.07 and a current ratio of 3.07. The stock has a market cap of $26.96 million, a PE ratio of -20.06 and a beta of 0.18. The firm’s 50 day moving average price is $33.80 and its two-hundred day moving average price is $34.87. AB Corporate Bond ETF has a one year low of $33.24 and a one year high of $36.46.

AB Corporate Bond ETF Increases Dividend

The company also recently disclosed a monthly dividend, which was paid on Thursday, November 5th. Stockholders of record on Monday, November 2nd were given a dividend of $0.1460 per share. This is a boost from AB Corporate Bond ETF’s previous monthly dividend of $0.1367. This represents a $1.75 dividend on an annualized basis and a dividend yield of 5.2%. The ex-dividend date was Monday, November 2nd. AB Corporate Bond ETF’s dividend payout ratio (DPR) is presently -102.38%.

About AB Corporate Bond ETF

EyeGate Pharmaceuticals, Inc. is a clinical stage specialty pharmaceutical company, which engages in the development and commercialization of products for treating diseases and disorders of the eye. Its pipeline includes MoxiGel and Ocular Bandage Gel. The company was founded in 1998 and is headquartered in Waltham, MA.